Drug intelligence / Profile preview

ketorolac trometamol + carboxymethylcellulose

Development stage
Phase 3
Lead developer
Allergan
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Ophthalmic
01

Overview

This is a fixed-dose combination ophthalmic solution containing ketorolac trometamol (also known as ketorolac tromethamine), a nonsteroidal anti-inflammatory drug (NSAID), and carboxymethylcellulose sodium, an ocular lubricant. The formulation is primarily indicated for the treatment of pain and inflammation following cataract surgery. Ketorolac acts by inhibiting prostaglandin biosynthesis through reversible inhibition of cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing inflammation and pain. Carboxymethylcellulose serves as a demulcent that lubricates the ocular surface, enhances corneal epithelial healing, prolongs drug residence time on the eye, and reduces irritation or dryness[2][4][5][10]. The combination improves ocular penetration of ketorolac compared to previous formulations without CMC[4].

Brand names
Acuvail
Other names
ketorolac tromethamine + carboxymethylcelluloseketorolac trometamol + CMCketorolac tromethamine ophthalmic solution 0.45%
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on ketorolac trometamol + carboxymethylcellulose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ketorolac trometamol + carboxymethylcellulose.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call